Breaking News Instant updates and real-time market news.

MCHP

Microchip

$83.46 /

-1.06 (-1.25%)

08:28
12/01/21
12/01
08:28
12/01/21
08:28

Microchip continues expansion of GaN RF power portfolio

Microchip Technology announced a significant expansion of its Gallium Nitride, GaN, Radio Frequency, RF, power device portfolio with new MMICs and discrete transistors that cover frequencies up to 20 gigahertz. The devices combine high power-added efficiency, PAE, and high linearity to deliver new levels of performance in applications ranging from 5G to electronic warfare, satellite communications, commercial and defense radar systems and test equipment. They include GaN MMICs covering 2 to 18 GHz, 12 to 20 GHz, and 12 to 20 GHz with 3 dB Compression Point RF output power up to 20 W and efficiency up to 25%, as well as bare die and packaged GaN MMIC amplifiers for S- and X-band with up to 60% PAE, and discrete high electron mobility transistor, HEMT, devices covering DC to 14 GHz with P3dB RF output power up to 100W and maximum efficiency of 70%. "Microchip continues to invest in our family of GaN RF products to support every application at all frequencies from microwave through millimeter wavelengths, and our product portfolio includes more than 50 devices, from low-power levels to 2.2 kW," said Leon Gross, vice president of Microchip's discrete products business unit. "Together the products announced today span 2 to 20 GHz and are designed to meet the linearity and efficiency challenges posed by the higher-order modulation techniques employed in 5G and other wireless networks, as well as the unique needs of satellite communications and defense applications."

  • 06

    Dec

OTHER BREAKING NEWS FROM THE FLY

Upgrade
Cytori Therapeutics upgraded to Overweight from Underweight at Barclays » 05:55
01/18/22
01/18
05:55
01/18/22
05:55
CYTX

Cytori Therapeutics

/

+

Barclays analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYTX Cytori Therapeutics
/

+

Conference/Events
Hannon Armstrong management to meet virtually with Oppenheimer » 05:55
01/18/22
01/18
05:55
01/18/22
05:55
HASI

Hannon Armstrong

$46.19 /

+0.025 (+0.05%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HASI Hannon Armstrong
$46.19 /

+0.025 (+0.05%)

HASI Hannon Armstrong
$46.19 /

+0.025 (+0.05%)

01/13/22 Morgan Stanley
Clean Tech industry view upgraded to Attractive at Morgan Stanley
12/23/21 B. Riley
B. Riley names top three solar and storage ideas for 2022
11/30/21 B. Riley
Hannon Armstrong price target raised to $83 from $82 at B. Riley
11/15/21 Roth Capital
Roth Capital not expecting A-SMACC to reveal petitioner to keep anti-circ case alive
HASI Hannon Armstrong
$46.19 /

+0.025 (+0.05%)

HASI Hannon Armstrong
$46.19 /

+0.025 (+0.05%)

Conference/Events
Despegar.com management to meet virtually with Morgan Stanley » 05:55
01/18/22
01/18
05:55
01/18/22
05:55
DESP

Despegar.com

$9.94 /

+0.22 (+2.26%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DESP Despegar.com
$9.94 /

+0.22 (+2.26%)

DESP Despegar.com
$9.94 /

+0.22 (+2.26%)

12/15/21 Cowen
Despegar.com price target lowered to $11 from $13 at Cowen
03/16/21 KeyBanc
Despegar.com upgraded to Overweight as travel resumes at KeyBanc
03/15/21 KeyBanc
Despegar.com upgraded to Overweight from Sector Weight at KeyBanc
DESP Despegar.com
$9.94 /

+0.22 (+2.26%)

Earnings
Truist Financial reports Q4 adjusted EPS $1.38, consensus $1.25 » 05:54
01/18/22
01/18
05:54
01/18/22
05:54
TFC

Truist Financial

$67.42 /

+0.64 (+0.96%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TFC Truist Financial
$67.42 /

+0.64 (+0.96%)

TFC Truist Financial
$67.42 /

+0.64 (+0.96%)

01/06/22 JPMorgan
Truist Financial price target raised to $68.50 from $67.50 at JPMorgan
01/03/22 Keefe Bruyette
Apollo long, Rocket short amid KBW's 13 best ideas for 2022
01/03/22 Barclays
Truist Financial price target raised to $72 from $64 at Barclays
12/09/21 UBS
Truist assumed with Neutral on low rate sensitivity at UBS
TFC Truist Financial
$67.42 /

+0.64 (+0.96%)

TFC Truist Financial
$67.42 /

+0.64 (+0.96%)

Upgrade
AvalonBay upgraded to Equal Weight from Underweight at Barclays » 05:53
01/18/22
01/18
05:53
01/18/22
05:53
AVB

AvalonBay

$248.78 /

-2.15 (-0.86%)

Barclays analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVB AvalonBay
$248.78 /

-2.15 (-0.86%)

AVB AvalonBay
$248.78 /

-2.15 (-0.86%)

01/13/22 KeyBanc
AvalonBay price target raised to $275 from $255 at KeyBanc
01/03/22 Deutsche Bank
AvalonBay upgraded to Buy from Hold at Deutsche Bank
12/13/21 BTIG
AvalonBay price target raised to $307 from $289 at BTIG
12/09/21 BMO Capital
AvalonBay upgraded to Outperform from Market Perform at BMO Capital
AVB AvalonBay
$248.78 /

-2.15 (-0.86%)

Upgrade
iRhythm upgraded to Overweight from Equal Weight at Morgan Stanley » 05:51
01/18/22
01/18
05:51
01/18/22
05:51
IRTC

iRhythm

$140.94 /

-1.69 (-1.18%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IRTC iRhythm
$140.94 /

-1.69 (-1.18%)

IRTC iRhythm
$140.94 /

-1.69 (-1.18%)

01/14/22 Canaccord
iRhythm price target raised to $160 from $125 at Canaccord
01/14/22 Citi
iRhythm price target raised to $165 from $120 at Citi
01/13/22 Truist
iRhythm price target raised to $185 from $130 at Truist
01/12/22 BTIG
iRhythm upgraded to Buy from Neutral at BTIG
IRTC iRhythm
$140.94 /

-1.69 (-1.18%)

  • 10
    Jun
IRTC iRhythm
$140.94 /

-1.69 (-1.18%)

Upgrade
Sunstone Hotel upgraded to Overweight from Equal Weight at Morgan Stanley » 05:51
01/18/22
01/18
05:51
01/18/22
05:51
SHO

Sunstone Hotel

$11.82 /

-0.005 (-0.04%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHO Sunstone Hotel
$11.82 /

-0.005 (-0.04%)

SHO Sunstone Hotel
$11.82 /

-0.005 (-0.04%)

01/10/22 BofA
Sunstone Hotel double downgraded to Underperform at BofA
12/03/21 Truist
Sunstone Hotel price target raised to $12 from $11 at Truist
11/14/21 Evercore ISI
Sunstone Hotel downgraded to In Line from Outperform at Evercore ISI
08/24/21
Fly Intel: Top five analyst upgrades
SHO Sunstone Hotel
$11.82 /

-0.005 (-0.04%)

SHO Sunstone Hotel
$11.82 /

-0.005 (-0.04%)

Initiation
Vonovia resumed with a Buy at Societe Generale » 05:49
01/18/22
01/18
05:49
01/18/22
05:49
VNNVF

Vonovia

$57.03 /

+2.684261 (+4.94%)

Societe Generale analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VNNVF Vonovia
$57.03 /

+2.684261 (+4.94%)

12/22/21 Barclays
Vonovia price target lowered to EUR 65 from EUR 71 at Barclays
12/16/21 Deutsche Bank
Vonovia resumed with a Buy at Deutsche Bank
12/13/21 Morgan Stanley
Vonovia resumed with an Overweight at Morgan Stanley
12/03/21 DZ Bank
Vonovia upgraded to Buy from Hold at DZ Bank
Downgrade
Airbnb downgraded to Hold from Buy at Gordon Haskett » 05:47
01/18/22
01/18
05:47
01/18/22
05:47
ABNB

Airbnb

$163.96 /

-2.04 (-1.23%)

Gordon Haskett analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ABNB Airbnb
$163.96 /

-2.04 (-1.23%)

ABNB Airbnb
$163.96 /

-2.04 (-1.23%)

01/14/22 Stifel
Expedia price target raised to $190 from $180 at Stifel
01/10/22 Piper Sandler
Airbnb downgraded to Neutral from Overweight at Piper Sandler
01/07/22 Jefferies
Airbnb assumed with a Buy at Jefferies
12/16/21 RBC Capital
Airbnb downgraded to Sector Perform at RBC Capital on 'balanced' risk-reward
ABNB Airbnb
$163.96 /

-2.04 (-1.23%)

ABNB Airbnb
$163.96 /

-2.04 (-1.23%)

ABNB Airbnb
$163.96 /

-2.04 (-1.23%)

ABNB Airbnb
$163.96 /

-2.04 (-1.23%)

Upgrade
Acushnet Holdings upgraded to Buy from Neutral at Compass Point » 05:46
01/18/22
01/18
05:46
01/18/22
05:46
GOLF

Acushnet Holdings

$49.19 /

-1.43 (-2.82%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOLF Acushnet Holdings
$49.19 /

-1.43 (-2.82%)

11/08/21 Roth Capital
Roth Capital ups Acushnet Holdings target to $65 after quarterly results
08/09/21 KeyBanc
Acushnet Holdings price target raised to $60 from $55 at KeyBanc
08/05/21 Roth Capital
Acushnet Holdings price target raised to $62 from $56 at Roth Capital
06/24/21 Truist
Acushnet Holdings price target raised to $50 from $48 at Truist
GOLF Acushnet Holdings
$49.19 /

-1.43 (-2.82%)

Downgrade
Neurocrine downgraded to Sector Perform from Outperform at RBC Capital » 05:42
01/18/22
01/18
05:42
01/18/22
05:42
NBIX

Neurocrine

$78.28 /

-0.895 (-1.13%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NBIX Neurocrine
$78.28 /

-0.895 (-1.13%)

NBIX Neurocrine
$78.28 /

-0.895 (-1.13%)

12/08/21 Raymond James
Raymond James sees 10% rally today for Neurocrine on Ingrezza data
12/08/21 Oppenheimer
Neurocrine price target raised to $154 from $140 at Oppenheimer
12/08/21 Citi
Neurocrine price target raised to $129 from $127 at Citi
11/18/21 BMO Capital
Neurocrine initiated with an Underperform at BMO Capital
NBIX Neurocrine
$78.28 /

-0.895 (-1.13%)

NBIX Neurocrine
$78.28 /

-0.895 (-1.13%)

NBIX Neurocrine
$78.28 /

-0.895 (-1.13%)

Upgrade
Incyte upgraded to Outperform from Sector Perform at RBC Capital » 05:41
01/18/22
01/18
05:41
01/18/22
05:41
INCY

Incyte

$74.90 /

+1.3 (+1.77%)

RBC Capital analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$74.90 /

+1.3 (+1.77%)

INCY Incyte
$74.90 /

+1.3 (+1.77%)

01/03/22 Guggenheim
Incyte price target lowered to $104 from $118 at Guggenheim
12/31/21 Benchmark
Incyte, Nektar, Compass Therapeutics named best biotech picks at Benchmark
11/18/21 BMO Capital
Incyte initiated with a Market Perform at BMO Capital
10/15/21 Cantor Fitzgerald
Incyte price target lowered to $79 from $104 at Cantor Fitzgerald
INCY Incyte
$74.90 /

+1.3 (+1.77%)

INCY Incyte
$74.90 /

+1.3 (+1.77%)

INCY Incyte
$74.90 /

+1.3 (+1.77%)

Hot Stocks
Sonida Senior Living announces December occupancy » 05:41
01/18/22
01/18
05:41
01/18/22
05:41
SNDA

Sonida Senior Living

$30.00 /

+1 (+3.45%)

Sonida Senior Living…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNDA Sonida Senior Living
$30.00 /

+1 (+3.45%)

Upgrade
Six Flags upgraded to Outperform from Perform at Oppenheimer » 05:39
01/18/22
01/18
05:39
01/18/22
05:39
SIX

Six Flags

$40.65 /

-0.87 (-2.10%)

Oppenheimer analyst Ian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIX Six Flags
$40.65 /

-0.87 (-2.10%)

SIX Six Flags
$40.65 /

-0.87 (-2.10%)

12/17/21 Credit Suisse
Six Flags upgraded to Outperform from Neutral at Credit Suisse
12/14/21 Goldman Sachs
Six Flags upgraded to Buy at Goldman after leisure group correction
12/14/21 Goldman Sachs
Six Flags upgraded to Buy from Neutral at Goldman Sachs
11/17/21
Fly Intel: Top five analyst initiations
SIX Six Flags
$40.65 /

-0.87 (-2.10%)

SIX Six Flags
$40.65 /

-0.87 (-2.10%)

SIX Six Flags
$40.65 /

-0.87 (-2.10%)

Downgrade
Sportradar downgraded to Equal Weight from Overweight at Morgan Stanley » 05:38
01/18/22
01/18
05:38
01/18/22
05:38
SRAD

Sportradar

$15.47 /

-0.07 (-0.45%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SRAD Sportradar
$15.47 /

-0.07 (-0.45%)

SRAD Sportradar
$15.47 /

-0.07 (-0.45%)

01/04/22 Craig-Hallum
Sportradar price target lowered to $30 from $35 at Craig-Hallum
11/18/21 Deutsche Bank
Sportradar price target lowered to $27 from $28 at Deutsche Bank
11/18/21 Citi
Sportradar price target lowered to $28 from $30 at Citi
10/11/21
Fly Intel: Top five analyst initiations
SRAD Sportradar
$15.47 /

-0.07 (-0.45%)

  • 14
    Sep
SRAD Sportradar
$15.47 /

-0.07 (-0.45%)

SRAD Sportradar
$15.47 /

-0.07 (-0.45%)

SRAD Sportradar
$15.47 /

-0.07 (-0.45%)

Downgrade
Choice Hotels downgraded to Underweight from Equal Weight at Morgan Stanley » 05:38
01/18/22
01/18
05:38
01/18/22
05:38
CHH

Choice Hotels

$152.05 /

-1.76 (-1.14%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHH Choice Hotels
$152.05 /

-1.76 (-1.14%)

CHH Choice Hotels
$152.05 /

-1.76 (-1.14%)

12/03/21 Truist
Choice Hotels price target raised to $125 from $114 at Truist
12/02/21
Fly Intel: Top five analyst downgrades
12/02/21 Loop Capital
Choice Hotels downgraded to Hold from Buy at Loop Capital
11/17/21
Fly Intel: Top five analyst downgrades
CHH Choice Hotels
$152.05 /

-1.76 (-1.14%)

Upgrade
Johnson Matthey upgraded to Hold from Sell at Panmure Gordon » 05:37
01/18/22
01/18
05:37
01/18/22
05:37
JMPLY

Johnson Matthey

$53.97 /

-0.93 (-1.69%)

Panmure Gordon analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JMPLY Johnson Matthey
$53.97 /

-0.93 (-1.69%)

JMPLY Johnson Matthey
$53.97 /

-0.93 (-1.69%)

01/14/22 Barclays
Johnson Matthey price target lowered to 2,320 GBp from 2,510 GBp at Barclays
01/13/22 JPMorgan
Johnson Matthey price target lowered to 2,600 GBp from 2,800 GBp at JPMorgan
01/06/22 Bernstein
Johnson Matthey downgraded to Market Perform from Outperform at Bernstein
12/02/21 Stifel
Johnson Matthey upgraded to Buy from Hold at Stifel
Hot Stocks
Ionis Pharmaceuticals partner Roche to design new tominersen trial » 05:36
01/18/22
01/18
05:36
01/18/22
05:36
IONS

Ionis Pharmaceuticals

$33.07 /

+0.895 (+2.78%)

, RHHBY

Roche

$50.30 /

+0.82 (+1.66%)

Ionis Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IONS Ionis Pharmaceuticals
$33.07 /

+0.895 (+2.78%)

RHHBY Roche
$50.30 /

+0.82 (+1.66%)

IONS Ionis Pharmaceuticals
$33.07 /

+0.895 (+2.78%)

12/28/21 Oppenheimer
Ionis weakness associated with peer ATTR failure 'misplaced,' says Oppenheimer
12/14/21 William Blair
Ionis upgraded to Outperform on pipeline opportunities at William Blair
12/14/21 William Blair
Ionis Pharmaceuticals upgraded to Outperform from Market Perform at William Blair
11/26/21 Mizuho
Pfizer data on vupanorsen is mixed, says Mizuho
RHHBY Roche
$50.30 /

+0.82 (+1.66%)

01/14/22 BofA
Biogen price target lowered to $245 from $275 at BofA
01/04/22 JPMorgan
Roche price target raised to CHF 390 from CHF 360 at JPMorgan
12/22/21 Citi
Roche resumed with a Buy at Citi
12/13/21 Credit Suisse
Roche price target raised to CHF 370 from CHF 350 at Credit Suisse
IONS Ionis Pharmaceuticals
$33.07 /

+0.895 (+2.78%)

RHHBY Roche
$50.30 /

+0.82 (+1.66%)

RHHBY Roche
$50.30 /

+0.82 (+1.66%)

RHHBY Roche
$50.30 /

+0.82 (+1.66%)

Upgrade
Siltronic upgraded to Outperform from Neutral at Oddo BHF » 05:35
01/18/22
01/18
05:35
01/18/22
05:35
SSLLF

Siltronic

$153.65 /

+ (+0.00%)

Oddo BHF analyst Stephane…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SSLLF Siltronic
$153.65 /

+ (+0.00%)

02/02/21 Berenberg
Siltronic price target raised to EUR 145 from EUR 125 at Berenberg
01/26/21 Deutsche Bank
Siltronic downgraded to Hold from Buy at Deutsche Bank
01/26/21 Stifel
Siltronic downgraded to Hold from Buy at Stifel
01/22/21 Oddo BHF
Siltronic downgraded to Neutral from Buy at Oddo BHF
Initiation
Daimler Truck Holding initiated with a Buy at DZ Bank » 05:35
01/18/22
01/18
05:35
01/18/22
05:35
DTRUY

Daimler Truck Holding

$20.11 /

+0.71 (+3.66%)

DZ Bank initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DTRUY Daimler Truck Holding
$20.11 /

+0.71 (+3.66%)

DTRUY Daimler Truck Holding
$20.11 /

+0.71 (+3.66%)

01/10/22 Stifel
Daimler Truck Holding initiated with a Buy at Stifel
01/04/22 RBC Capital
Daimler Truck Holding initiated with an Outperform at RBC Capital
12/13/21 Citi
Daimler Truck Holding initiated with a Buy at Citi
General news
FX Action: USD-JPY » 05:35
01/18/22
01/18
05:35
01/18/22
05:35
$ECON

Economic Data

/

+

FX Action: USD-JPY is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Upgrade
Zscaler upgraded to Overweight from Equal Weight at Morgan Stanley » 05:34
01/18/22
01/18
05:34
01/18/22
05:34
ZS

Zscaler

$254.94 /

+4.57 (+1.83%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZS Zscaler
$254.94 /

+4.57 (+1.83%)

ZS Zscaler
$254.94 /

+4.57 (+1.83%)

01/10/22 UBS
Zscaler upgraded to Buy from Neutral at UBS
01/06/22 Piper Sandler
Zscaler price target lowered to $295 from $365 at Piper Sandler
01/05/22 Wells Fargo
Zscaler initiated with an Overweight at Wells Fargo
12/15/21 Mizuho
Zscaler price target lowered to $385 from $400 at Mizuho
ZS Zscaler
$254.94 /

+4.57 (+1.83%)

ZS Zscaler
$254.94 /

+4.57 (+1.83%)

ZS Zscaler
$254.94 /

+4.57 (+1.83%)

Upgrade
Indutrade upgraded to Buy from Hold at Danske Bank » 05:34
01/18/22
01/18
05:34
01/18/22
05:34
IDDWF

Indutrade

$58.92 /

+ (+0.00%)

Danske Bank analyst Johan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Molecular Partners, Novartis enter ensovibep license agreement » 05:33
01/18/22
01/18
05:33
01/18/22
05:33
MOLN

Molecular Partners

$31.61 /

+3.515 (+12.51%)

, NVS

Novartis

$90.53 /

-0.09 (-0.10%)

Molecular Partners (MOLN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOLN Molecular Partners
$31.61 /

+3.515 (+12.51%)

NVS Novartis
$90.53 /

-0.09 (-0.10%)

MOLN Molecular Partners
$31.61 /

+3.515 (+12.51%)

01/14/22 Credit Suisse
Molecular Partners price target raised to CHF 23 from CHF 17 at Credit Suisse
01/14/22 SVB Leerink
Molecular Partners price target raised to $42 from $35 at SVB Leerink
08/10/21 Credit Suisse
Molecular Partners price target lowered to CHF 18.50 at Credit Suisse
07/12/21 Cowen
Molecular Partners initiated with an Outperform at Cowen
NVS Novartis
$90.53 /

-0.09 (-0.10%)

01/12/22 Alliance Global Partners
OpGen price target lowered to $3 from $4.35 at Alliance Global Partners
01/10/22 Citi
Novartis resumed with a Buy at Citi
01/06/22 Piper Sandler
Piper want to own Alnylam shares ahead of expected vutrisiran approval
12/15/21 Berenberg
Novartis price target lowered to CHF 85 from CHF 88 at Berenberg
NVS Novartis
$90.53 /

-0.09 (-0.10%)

  • 16
    Jun
NVS Novartis
$90.53 /

-0.09 (-0.10%)

NVS Novartis
$90.53 /

-0.09 (-0.10%)

NVS Novartis
$90.53 /

-0.09 (-0.10%)

Downgrade
Nordea Bank downgraded to Hold from Buy at Pareto » 05:33
01/18/22
01/18
05:33
01/18/22
05:33
NRDBY

Nordea Bank

$12.87 /

-0.24 (-1.83%)

Pareto analyst Herman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRDBY Nordea Bank
$12.87 /

-0.24 (-1.83%)

NRDBY Nordea Bank
$12.87 /

-0.24 (-1.83%)

12/15/21 Credit Suisse
Nordea Bank downgraded to Neutral from Outperform at Credit Suisse
11/01/21 Barclays
Nordea Bank price target raised to EUR 11.20 from EUR 10.50 at Barclays
10/25/21 UBS
Nordea Bank price target raised to SEK 120 from SEK 115 at UBS
10/22/21 Credit Suisse
Nordea Bank price target raised to EUR 12 from EUR 11 at Credit Suisse

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.